← Back to Search

Amino Acid Supplement

Oral Supplement for Type 2 Diabetes

N/A
Waitlist Available
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 10, 20, 40, 60, 120 ± 5 min after isotope infusion

Summary

This trial is testing whether isoleucine affects TCA cycle function in obese, insulin resistant type 2 diabetics, and whether this can help control and coordinate complex patterns of force.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 10, 20, 40, 60, 120 ± 5 min after isotope infusion
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 10, 20, 40, 60, 120 ± 5 min after isotope infusion for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in whole-body protein metabolism in type 2 diabetic obese subjects
Secondary study objectives
24-hour glucose levels in type 2 diabetic obese subjects
Changes in attention and executive functions as measured by Brief-A in type 2 diabetics obese subjects
Changes in attention and executive functions as measured by Trail Making Test (TMT) in type 2 diabetics obese subjects
+6 more
Other study objectives
Group differences in Bi-manual Coordination Task between type 2 diabetics and non-diabetic subjects
Group differences in Reaction Time task between type 2 diabetics and non-diabetic subjects
Group differences in balance between type 2 diabetics and non-diabetic subjects
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: IsoleucineExperimental Treatment1 Intervention
Type 2 Diabetics randomized to isoleucine group
Group II: HealthyActive Control1 Intervention
gender-, age-, BMI-matched controls for baseline measurements only. No supplementation provided.
Group III: PlaceboPlacebo Group1 Intervention
Type 2 Diabetics randomized to placebo group

Find a Location

Who is running the clinical trial?

Texas A&M UniversityLead Sponsor
147 Previous Clinical Trials
23,773 Total Patients Enrolled
~14 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top